What are the normal ranges for Prothrombin Time (PT)/International Normalized Ratio (INR) and Activated Partial Thromboplastin Time (APTT) values?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Values for PT/INR and APTT

The normal reference range for Prothrombin Time (PT) is typically 11-13.5 seconds, for International Normalized Ratio (INR) is 0.8-1.2, and for Activated Partial Thromboplastin Time (APTT) is 25-35 seconds, though exact values may vary slightly between laboratories. 1

Normal Reference Ranges

  • PT typically ranges from 11-13.5 seconds in healthy individuals not on anticoagulation therapy 1
  • INR in healthy individuals not on anticoagulant therapy normally ranges from 0.8-1.2 2
  • APTT typically ranges from 25-35 seconds in individuals with normal coagulation function 1, 3

Clinical Significance of These Values

  • INR was specifically designed and validated to standardize PT results for monitoring vitamin K antagonist therapy (like warfarin), not as a general predictor of bleeding risk in other contexts 4
  • For patients on warfarin therapy, the therapeutic INR range is typically 2.0-3.0 for most indications 5, 6
  • Higher INR targets (2.5-3.5) may be required for specific conditions such as mechanical heart valves 7
  • The risk of bleeding increases exponentially when INR exceeds 5.0 7

Factors Affecting PT/INR and APTT Values

  • PT/INR can be prolonged due to vitamin K deficiency, liver disease, or anticoagulant therapy 1
  • APTT can be prolonged due to lupus anticoagulant, hemophilia, or heparin therapy 1
  • Both PT/INR and APTT can be prolonged in conditions affecting multiple coagulation factors, such as liver disease or disseminated intravascular coagulation 1

Interpretation in Different Clinical Contexts

  • For patients not on anticoagulation therapy, a PT ratio or APTT ratio >1.4 times the normal control is generally considered abnormal 5
  • For patients on vitamin K antagonist therapy, INR values between 2.0-3.0 are typically targeted for most indications 5
  • In certain high-risk conditions (such as mechanical heart valves), a higher INR target of 2.5-3.5 may be recommended 7

Important Considerations

  • Storage conditions affect stability of PT/INR and APTT test results - samples are stable for up to 36 hours when frozen, but deteriorate within 12 hours at room temperature 3
  • The INR system was specifically designed to standardize PT results for patients on vitamin K antagonist therapy and may not accurately reflect bleeding risk in other clinical scenarios 4
  • Different laboratories may have slightly different reference ranges based on their specific reagents and testing methods 2, 8

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.